Introduction
============

Acute and chronic gastrointestinal (GI) inflammatory disease conditions are associated with persistent oxidative stress originating from increased reactive oxygen species (ROS) that are known to initiate and perpetuate inflammation ([@B8]; [@B31]). Oxidative stress-induced epithelial cell damage and increased intestinal permeability toward luminal commensal bacterial material, which activates mucosal immune cells and triggers muscular inflammation, can contribute to the severity of acute GI disorders as observed in animal models of septic ileus, necrotizing enterocolitis and ischemia/reperfusion injury ([@B2]; [@B19]; [@B7]; [@B18]; [@B23]). Excessive production of ROS and mucosal injury has also been reported in animal models of inflammatory bowel disease (IBD) ([@B1]; [@B41]; [@B12]) and in colonic tissue of patients with ulcerative colitis ([@B39]; [@B38]). Tumor necrosis factor (TNF)-α is one of the early inflammatory mediators thought to play an important role in epithelial barrier dysfunction by inducing intestinal epithelial cell (IEC) apoptosis. ROS play an important role in TNF-α-induced apoptotic cell death of IECs ([@B28]; [@B7]; [@B6]). The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) family and the mitochondrial electron transport chain (ETC) are the two major ROS-producing sources involved in TNF-α/cycloheximide (CHX)-induced cell death in rat IEC-6 cells ([@B28]) and in mouse MODE-K cells ([@B4]). In MODE-K cells in particular, complexes I and II of the mitochondrial ETC were found to be the main sites of superoxide anion ($O_{2}^{\bullet –}$) production in addition to NOX ([@B4]). As the endogenous antioxidant defense system does not seem sufficient to counteract TNF-α-induced ROS production, neutralizing excessive ROS production might be an effective therapeutic strategy to reduce intestinal barrier dysfunction during GI inflammation.

The stress-responsive protein heme oxygenase (HO)-1 is up-regulated by oxidative stress and inflammatory signals, and it generates biliverdin, a powerful antioxidant, and carbon monoxide (CO), which exerts antioxidant, anti-inflammatory and cytoprotective effects ([@B44]; [@B35]). Inhalation of CO gas has been successfully applied in animal models of inflammation and oxidative stress but translation to humans might be difficult ([@B27]). From pharmacological and therapeutic perspectives, small molecules capable of delivering controlled amounts of CO to biological systems have therefore been developed to mimic the intrinsic beneficial effects of CO ([@B32]; [@B45]; [@B35]). These compounds, known as CO-releasing molecules (CO-RMs), have been extensively studied and belong to two major classes: (1) metal carbonyl complexes containing ruthenium, manganese, or molybdenum, which carry CO bound to the transition metal and (2) boranocarbonates, which do not contain transition metals but the metalloid boron and release CO spontaneously in physiological conditions, the rate of release being affected by changes in pH. While the original lipophilic CO-RMs such as CORM-1 (\[Mn~2~(CO)~10~\]) and CORM-2 (\[Ru(CO)~3~Cl~2~\]~2~) have to be dissolved in organic solvents such as dimethyl sulfoxide (DMSO) ([@B32]), water-soluble CO-RMs such as CORM-3 (\[Ru(CO)~3~Cl(glycinate)\]) and CORM-A1 (Na~2~\[H~3~BCO~2~\]) were subsequently developed ([@B15]; [@B36]). These compounds have been shown to be pharmacologically active in limiting cellular and tissue dysfunctions in a number of pathological disorders associated with inflammation and tissue injury ([@B33]). The inhibitory effect of CO and CO-RMs on cytokine-induced changes in the intestinal epithelium might also contribute to their beneficial effect in acute GI inflammation such as postoperative ileus ([@B5]) and in chronic GI inflammation such as IBD ([@B50]). Although the exact mechanism(s) for the antioxidant and cytoprotective effect of CO is (are) still under investigation, emerging evidence indicates that the beneficial properties of CO may be linked to its ability to bind to hemoproteins, such as NOX and mitochondrial complexes in different tissues ([@B49]; [@B11]). At the mitochondrial level, CO was shown to induce a transient burst of mitochondrial ROS ($O_{2}^{\bullet –}$) that is thought to promote a preconditioning state, enabling it to counteract subsequent oxidative stress ([@B49]; [@B14]; [@B55]). We previously showed that the water-soluble CORM-A1 reduced both TNF-α/CHX-induced ROS production and apoptosis in MODE-K IECs ([@B6], [@B3]). At cytoprotective concentrations, CORM-A1 *per se* did not induce mitochondrial $O_{2}^{\bullet –}$; however, CORM-A1 inhibited NOX-derived ROS production, but not mitochondrial $O_{2}^{\bullet –}$ production, after challenging MODE-K IECs with TNF-α ([@B3]). This absence of an effect at the mitochondrial level might be related to the water-soluble properties of this CO-RM, which prevent its penetration to sites of ROS production in mitochondria. By contrast, the lipophilic CORM-2 was shown to induce ROS production from mitochondria in human bronchial smooth muscle cells ([@B49]). The cytoprotective properties of CORM-2 in IECs and its effect on cellular targets mediating ROS production have yet to be investigated. CORM-401 \[Mn(CO)~4~{S~2~CNMe(CH~2~CO~2~H)}\] is a recently developed water-soluble CO-RM that releases up to three equivalents of CO per mole of compound, in contrast to CORM-A1 which releases one equivalent of CO ([@B34]; [@B17]; [@B21]). Moreover, the rate of CO release from CORM-401 in cell-free *in vitro* systems is accelerated in the presence of biologically relevant oxidants, such as hydrogen peroxide (H~2~O~2~) ([@B21]).

In view of the above considerations, in the present study, we compared the cytoprotective effects of CORM-2 and CORM-401 in MODE-K IECs under oxidative stress conditions, evaluating their effects on oxidant-generating system(s). For the protocol with a high concentration of H~2~O~2~, also CORM-A1 was compared as this was not investigated in our previous study with the compound ([@B3]). The major characteristics of the three CO-RMs are summarized in **Table [1](#T1){ref-type="table"}**.

###### 

Structure and characteristics of CO-RMs studied.

  --
  --

Materials and Methods {#s1}
=====================

Chemicals and Reagents
----------------------

Reagents for cell culture, including Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, penicillin/streptomycin and GlutaMAX were obtained from Gibco BRL (Grand Island, NY, USA). Carboxylated analog of 2′7′-dichlorodihydrofluorescein diacetate acetyl ester (carboxy-H~2~DCFDA), MitoTracker Deep Red FM, MitoTracker Green FM, MitoSOX Red, Sytox Green, Sytox Red and tetramethylrhodamine methyl ester (TMRM) were purchased from Molecular Probes -- Invitrogen (Carlsbad, CA, USA). Recombinant murine TNF-α was purchased from R&D systems (Minneapolis, MN, USA). Antimycin-A, CHX, CORM-2, DMSO, H~2~O~2~ and rotenone were purchased from Sigma (St. Louis, MO, USA). CORM-A1 and CORM-401 were synthesized as previously described ([@B36]; [@B17]). Stock solutions of CORM-2 were prepared in DMSO, whereas CORM-401 was dissolved in phosphate buffered saline (PBS); the solutions were both protected from light in all experiments. Inactive CORM-2 (iCORM-2) was prepared by keeping the stock solution in DMSO for 18 h at 37°C in a 5% CO~2~ humidified atmosphere to liberate CO ([@B48]). As CORM-401 solutions as such are stable, no iCORM-401 comparable to iCORM-2 can be prepared. [@B21] used a mixture of equimolar amounts of Na~2~CNMeCO~2~Na.nH~2~O and MnSO~4~ as a surrogate iCORM-401 as these compounds compose the skeletal basis of the CORM-401 molecule without CO; this mixture did not reproduce the effects of CORM-401 in the *in vitro* models of vascular relaxation and angiogenesis studied. H~2~O~2~, obtained in a liquid formulation, was dissolved in culture medium. All other chemicals were dissolved in DMSO, except TNF-α, which was dissolved in PBS.

Cell Culture
------------

The mouse small IEC line, MODE-K (a generous gift from Dr. Ingo B. Autenrieth, University of *Tübingen*, Germany) was used in our study. This cell line was derived from the duodenum-jejunum from normal young C3H/HeJ mouse immortalized by simian virus (SV)-40 large T gene transfer. The cells are undifferentiated but still exhibit morphological and phenotypic characteristics of normal enterocytes ([@B54]). MODE-K cells (passage 10--35) were cultured in DMEM medium supplemented with 10% fetal bovine serum, 2 mM [L]{.smallcaps}-glutamine, and 5% penicillin (10,000 units/ml) with streptomycin (10 mg/ml). Cultures were maintained in a humidified 5% CO~2~ atmosphere at 37°C, and experiments were conducted on cells at approximately 80--90% confluence. MODE-K cells were seeded in culture medium containing 10% serum, grown for 36 h, and then serum-starved overnight. Cells were seeded at either 1 × 10^4^ cells per 200 μL of culture medium per well in a 96-well microtiter plate (for cell viability assay) or 2.5 × 10^5^ cells per 2 mL of culture medium per well in a six-well plate (for all other assays).

Treatment Protocols
-------------------

At 48 h after seeding, MODE-K cells were exposed to oxidative stress by treatment with 1 ng/ml TNF-α plus 10 μg/ml CHX for 6 h, 1 mM H~2~O~2~ for 40 min, 7.5 mM H~2~O~2~ for 1 h, 7.5 μM rotenone for 6 h, or 10 μM antimycin-A for 6 h. To study the influence of CORM-2 and CORM-401 vs. the oxidant stimuli, CO-RMs were pre-incubated from 1 h before exposure to the oxidative stress stimulus, followed by co-incubation of CO-RMs with the stimulus. However, for the experiments involving 7.5 mM H~2~O~2~ for 1 h, CORM-2 and CORM-401 were also just pre-incubated for 1 h or only co-incubated for 1 h; CORM-A1 was also studied vs. 7.5 mM H~2~O~2~, as this was not performed in the previous study on CORM-A1 ([@B3]).

CORM-2 and CORM-401 were used at 40 and 50 μM, respectively, as these were the highest concentrations without an effect *per se* on cell viability of MODE-K cells when incubated for 12 h (*n* = 3 for each compound, data not shown). CORM-A1 was studied at 100 μM, as determined earlier with the same assay ([@B6], [@B3]).

Determination of Cell Viability
-------------------------------

Cell viability was assessed by luminescent cell viability assay with CellTiter-Glo (Promega, Madison, WI, USA) according to the manufacturer's protocol. This assay determines the number of viable cells in culture based on quantitation of ATP, an indicator of metabolically active cells. Briefly, MODE-K cells were plated into 96-well plates and treated as described under cell culture. At the end of the incubation period for 12 h with CO-RMs on day 3, an equal volume of the luminescent substrate and lysis buffer mix from the assay kit was added. The mixture was transferred to an opaque 96-well plate, and luminescence was recorded using a GloMax Microplate Luminometer (Promega). The index of cellular viability was calculated as the percentage of luminescence with respect to untreated control cells.

Simultaneous Determination of Intracellular Total ROS Generation and Cell Death
-------------------------------------------------------------------------------

ROS production and cell death were measured simultaneously by flow cytometry, allowing measurement of ROS production in gated viable cells. Carboxy-H~2~DCFDA is a cell-permeable ROS indicator that is non-fluorescent until the acetate groups are removed by intracellular esterases and oxidation occurs within the cell. When oxidized by various active oxygen species, it is irreversibly converted to the fluorescent form, DCF. The fluorescence generated by DCF is proportional to the rate of carboxy-H~2~DCFDA oxidation, which is in turn indicative of the cellular oxidizing activity and intracellular ROS levels. The cells were loaded in the dark with 10 μM carboxy-H~2~DCFDA for 40 min before the end of the treatment period with a given oxidant stimulus. The floating and adherent cells were collected by trypsinization and washed twice with HBSS with calcium and magnesium. Sytox Red (2.5 nM) dead cell stain was added to the cell suspension, and simultaneous detection of ROS production and cell death was performed in a single experimental setup by flow cytometry using 488 nm excitation wavelength with 530/30 nm (FL1; DCF) and 670/30 (FL4; Sytox Red) emission filters. Viable (Sytox Red-negative) cells were gated, and the green fluorescence of the ROS probe was analyzed in these cells.

Simultaneous Determination of Mitochondrial $O_{2}^{\bullet –}$ Anion and Cell Death
------------------------------------------------------------------------------------

MitoSOX Red was used to detect mitochondrial $O_{2}^{\bullet –}$ production. This modified cationic dihydroethidium dye localizes to the mitochondria where it is oxidized by $O_{2}^{\bullet –}$ to generate bright red fluorescence ([@B42]). Mitochondrial $O_{2}^{\bullet –}$ generation and cell death were determined in a single experimental setup by treating the cell samples with MitoSOX Red and Sytox Red. The cells were loaded in the dark with 5 μM MitoSOX Red for 30 min before the end of the treatment period with a given oxidant stimulus, collected, washed twice with HBSS, and then stained with 2.5 nM Sytox Red. The samples were run on a flow cytometer with 488 nm excitation to measure oxidized MitoSOX Red in the FL2 channel and Sytox Red in the FL4 channel. Cell debris with low FSC (forward scatter) and SSC (side scatter) was excluded from the analysis. The mean fluorescence intensity (MFI) of MitoSOX Red staining was analyzed in the gated viable cell population (Sytox Red-negative). Thus, MitoSOX Red of the cells analyzed excluded any non-specific interference from dead cells.

For all experiments with analysis of ROS, (a) the fluorescence properties of at least 30,000 cells were acquired from each sample; (b) the samples were analyzed immediately after ending the incubation with the ROS indicator and strictly protected from light; (c) basal ROS generation in cells not exposed to TNF-α/CHX, H~2~O~2~, rotenone or antimycin-A, in culture medium alone or in medium containing the solvent of the drug to be studied vs. the oxidative stress stimulus, was used as a control; and (d) the MFIs of treated samples were expressed as percentage of the control MFI (set as 100%).

Measurement of Mitochondrial Dysfunction
----------------------------------------

Determination of respiratory chain damage was performed by double staining with two different mitochondria-specific dyes, MitoTracker Green FM and MitoTracker Deep Red FM, to distinguish total and respiring mitochondria, respectively. Mitochondria in cells stained with MitoTracker Green FM dye exhibit bright green fluorescein-like fluorescence (FL1; fluorescence emission at 516 nm) as this dye accumulates in the lipid environment of mitochondria regardless of Ψ~m~ and becomes fluorescent. MitoTracker Deep Red FM does not fluoresce until it enters an actively respiring cell, where it is oxidized to the corresponding red fluorescence probe (FL4; fluorescence emission at 665 nm) that then sequesters in the mitochondria in proportion to Ψ~m~ ([@B16]; [@B51]). So, MitoTracker Green will stain all mitochondria while MitoTracker Deep Red FM will stain active respiring mitochondria. The treated cells were incubated with 200 nM MitoTracker Green FM and 25 nM MitoTracker Deep Red FM in the dark at 37°C for 30 min before the end of the treatment period. Next, the cells were harvested and the pellets were suspended in 0.5 mL of PBS. The samples were analyzed immediately by flow cytometry. The percentage of MitoTracker Green-positive/MitoTracker Deep Red-negative cells is an important parameter of accumulation of cells with non-respiring (dysfunctional) mitochondria ([@B57]).

Simultaneous Determination of Mitochondrial Membrane Potential (Ψ~m~) and Cell Death
------------------------------------------------------------------------------------

Determination of the changes in mitochondrial membrane potential (Ψ~m~) was performed using TMRM along with staining of Sytox Green (for cell death). TMRM is a cell-permeant, lipophilic cationic, red--orange fluorescent dye that is readily sequestered by active mitochondria. TMRM is a single wavelength dye that can be combined with a cell death marker to measure fluorescence exclusively in the viable cells. Briefly, following the treatment, the cells were washed twice with HBSS and then incubated with 200 nM TMRM solution prepared in DMEM medium for 30 min. Subsequently, the cells were washed twice with HBSS and stained with 2 nM Sytox Green prior to measurement. The percentage of TMRM and Sytox Green stained cells was calculated from at least 30,000 cells of each sample in comparison to the control. TMRM was excited at 488 nm, and fluorescence emitted at 588 nm (FL2) was measured in gated viable (Sytox Green-negative) cells by flow cytometry.

For assays of ROS, mitochondrial dysfunction and Ψ~m~, the samples were acquired using a BD LSR II flow cytometer and analyzed using FACSDiva software (BD Biosciences, San Jose, CA, USA).

Statistical Analysis
--------------------

All data are expressed as the mean ± SEM. The comparison of the means was performed using Student's *t*-test for two groups of data and ANOVA followed by Bonferroni's multiple comparison test for comparison of more than two groups. Differences were considered significant at *P* \< 0.05.

Results
=======

Effects of CORM-2 and CORM-401 on TNF-α/CHX-Induced Changes in Intracellular Total ROS Production and Cell Death
----------------------------------------------------------------------------------------------------------------

To determine whether CORM-2 and CORM-401 could modulate ROS production and exert cytoprotection during inflammatory conditions, TNF-α/CHX-induced intracellular total ROS production and cell death were simultaneously measured by flow cytometry. Treatment of MODE-K cells with TNF-α/CHX for 6 h increased total ROS by approximately 200% (**Figures [1A,C](#F1){ref-type="fig"}**) and induced approximately 50% cell death (**Figures [1B,D](#F1){ref-type="fig"}**). Treatment of MODE-K cells with CORM-2 *per se* was without effect, but CORM-2 abolished TNF-α/CHX-induced ROS production (**Figure [1A](#F1){ref-type="fig"}**) with a significant reduction of cell death (**Figure [1B](#F1){ref-type="fig"}**); iCORM-2 had no effect *per se* nor did it influence the TNF-α/CHX-induced changes (data not shown). CORM-401 *per se* did not affect basal total ROS production and cell survival. Treatment of cells with CORM-401 significantly reduced both TNF-α/CHX-induced ROS production and cell death (**Figures [1C,D](#F1){ref-type="fig"}**).

![Effects of CORM-2 **(A,B)** or CORM-401 **(C,D)** on TNF-α/CHX-induced intracellular total ROS production and cell death in MODE-K cells. MODE-K cells were treated for 6 h with TNF-α (1 ng/ml) plus CHX (10 μg/ml) in the absence or presence of CORM-2 (40 μM) or CORM-401 (50 μM), added 1 h before TNF-α/CHX. Intracellular total ROS levels are assessed with carboxy-H~2~DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels were expressed as % of control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. TNF-α/CHX alone.](fphar-08-00031-g001){#F1}

Effects of CORM-2 and CORM-401 on H~2~O~2~-Induced Changes in Intracellular Total ROS Production
------------------------------------------------------------------------------------------------

The capacity of CORM-2 and CORM-401 to modulate oxidant-generating system(s) was further investigated *in vitro* using the model of H~2~O~2~-induced oxidative stress in MODE-K cells. First, incubation of cells with 1 mM H~2~O~2~ for 40 min was studied, as this condition was previously shown to induce a level of intracellular total ROS production relatively similar to that induced by TNF-α/CHX treatment for 6 h, albeit without inducing cell death ([@B4]). H~2~O~2~ increased ROS production by 430--505% compared with control (**Figures [2A,C](#F2){ref-type="fig"}**) indeed without inducing cell death (**Figures [2B,D](#F2){ref-type="fig"}**). Both CORM-2 and CORM-401 significantly attenuated the H~2~O~2~-induced increase in total ROS production (**Figures [2A,C](#F2){ref-type="fig"}**).

![**(A--D)** Effects of CORM-2 **(A,B)** or CORM-401 **(C,D)** on H~2~O~2~-induced intracellular total ROS production and cell death in MODE-K cells. MODE-K cells were treated for 40 min with H~2~O~2~ (1 mM) in the absence or presence of CORM-2 (40 μM) or CORM-401 (50 μM), added 1 h before H~2~O~2~. Intracellular total ROS levels were assessed with carboxy-H~2~DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels are expressed as % of control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. H~2~O~2~ alone. **(E,F)** Influence of H~2~O~2~ on intracellular total ROS production and cell death, measured as described for **(A--D)**. MODE-K cells were treated for 1 h with 2.5--10 mM H~2~O~2~. Control cells were incubated with serum-free medium alone. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control.](fphar-08-00031-g002){#F2}

As the release of CO from CORM-401 has been shown to be accelerated by increasing concentrations of oxidants, a concentration-response curve to H~2~O~2~ higher than 1 mM was constructed, assessing both intracellular total ROS production and cell death (**Figures [2E,F](#F2){ref-type="fig"}**). From these experiments, incubation of cells with 7.5 mM H~2~O~2~ for 1 h was selected as this condition induced a level of cell death similar to that induced by TNF-α/CHX for 6 h, i.e., 57 ± 4% (**Figure [2F](#F2){ref-type="fig"}**); this concentration of H~2~O~2~ increased ROS production by 2900% relative to the control (**Figure [2E](#F2){ref-type="fig"}**).

When the standard treatment protocol was used for CORM-2 (i.e., pre-treatment for 1 h before exposure to H~2~O~2~ and then co-treatment during exposure to H~2~O~2~), H~2~O~2~-induced ROS production and cell death were significantly reduced by 34 ± 10% and 41 ± 4%, respectively (*n* = 3; **Figures [3A,B](#F3){ref-type="fig"}**). By contrast, either pre-treatment with CORM-2 for 1 h or co-treatment with CORM-2 during the 1 h exposure to H~2~O~2~ did not affect H~2~O~2~-induced ROS production (**Figure [3A](#F3){ref-type="fig"}**) or cell death (**Figure [3B](#F3){ref-type="fig"}**). Pre-treatment of cells with CORM-401 followed by co-treatment with CORM-401 and H~2~O~2~ was even more effective as it decreased both H~2~O~2~-induced ROS production and cell death by 75 ± 5% and 72 ± 6%, respectively (*n* = 3; **Figures [3C,D](#F3){ref-type="fig"}**). Interestingly, and in contrast to the observations made with CORM-2, just pre-treating cells with CORM-401 for 1 h or just co-treating them with CORM-401 during the 1 h exposure to H~2~O~2~ was sufficient to significantly reduce H~2~O~2~-induced ROS production and cell death, although to a lesser extent compared with the pre- plus co-treatment protocol (*n* = 3; **Figures [3C,D](#F3){ref-type="fig"}**). Another water-soluble CO-RM, CORM-A1 showed similar effects as CORM-2 (*n* = 3; **Figures [3E,F](#F3){ref-type="fig"}**).

![Effects of CORM-2 **(A,B)**, CORM-401 **(C,D)** or CORM-A1 **(E,F)** on H~2~O~2~-induced intracellular total ROS production and cell death in MODE-K cells. MODE-K cells were treated for 1 h with H~2~O~2~ (7.5 mM); CORM-2 (40 μM), CORM-401 (50 μM) or CORM-A1 (100 μM) was either pre-incubated for 1 h and then co-incubated with H~2~O~2~ for 1 h (vertical striped bars), only pre-incubated for 1 h (horizontal striped bars) or co-incubated with H~2~O~2~ for 1 h (transverse striped bars). Intracellular total ROS levels were assessed with carboxy-H~2~DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels are expressed as % of control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2, CORM-401 or CORM-A1 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. H~2~O~2~ alone.](fphar-08-00031-g003){#F3}

Effects of CORM-2 and CORM-401 on TNF-α/CHX-Induced Changes in Mitochondrial $O_{2}^{\bullet –}$ Production and Cell Death
--------------------------------------------------------------------------------------------------------------------------

The influence of CORM-2 and CORM-401 on TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production was assessed by using the fluorescent probe MitoSOX Red in conjunction with Sytox Red, to discriminate viable vs. dead cells, in a single experimental setup. Exposure of cells to TNF-α/CHX increased mitochondrial $O_{2}^{\bullet –}$ production by approximately 200% relative to the control, and treatment with CORM-2 reduced this effect (**Figure [4A](#F4){ref-type="fig"}**) alongside a concomitant decrease in TNF-α/CHX-induced cell death (**Figure [4B](#F4){ref-type="fig"}**). iCORM-2 had no effect *per se* nor did it influence the TNF-α/CHX-induced changes (data not shown). By contrast, although CORM-401 significantly reduced TNF-α/CHX-induced cell death (**Figure [4D](#F4){ref-type="fig"}**), it did not influence TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production (**Figure [4C](#F4){ref-type="fig"}**).

![**(A--D)** Effects of CORM-2 **(A,B)** or CORM-401 **(C,D)** on TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production and cell death in MODE-K cells. MODE-K cells were treated for 6 h with TNF-α (1 ng/ml) plus CHX (10 μg/ml) in the absence or presence of CORM-2 (40 μM) or CORM-401 (50 μM), added 1 h before TNF-α/CHX. Mitochondrial $O_{2}^{\bullet –}$ levels were assessed with MitoSOX Red, and gated on the viable, Sytox Red-negative population. Mitochondrial $O_{2}^{\bullet –}$ levels are expressed as % of control MitoSOX Red MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 *vs.* control. ^\#^*P* \< 0.05 vs. TNF-α/CHX alone. **(E,F)** Influence of CORM-2 (40 μM) or CORM-401 (50 μM) *per se*, incubated for 1--3 h, on levels of mitochondrial $O_{2}^{\bullet –}$ **(E)**, measured as described for (**A--D)**, and intracellular total ROS **(F)**, measured as described in **Figure [1](#F1){ref-type="fig"}**. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. untreated control at the given time point.](fphar-08-00031-g004){#F4}

Incubated for 7 h, neither CORM-2 nor CORM-401 *per se* increased mitochondrial $O_{2}^{\bullet –}$ production (**Figures [4A,C](#F4){ref-type="fig"}**). When treating the cells for 1, 2, or 3 h, CORM-2 promoted a significant increase in mitochondrial $O_{2}^{\bullet –}$ when incubated for 2 h, whereas CORM-401 did not change mitochondrial $O_{2}^{\bullet –}$ production (**Figure [4E](#F4){ref-type="fig"}**); also iCORM-2 was without effect (data not shown). Treatment with CORM-2 or CORM-401 did not result in an increase in intracellular total ROS production at these time points (**Figure [4F](#F4){ref-type="fig"}**).

Effects of CORM-2 and CORM-401 on Mitochondrial Complex I- and Complex III-Induced Changes in Mitochondrial $O_{2}^{\bullet –}$ and Cell Death
----------------------------------------------------------------------------------------------------------------------------------------------

Rotenone (7.5 μM), an inhibitor of mitochondrial complex I, induced an increase in mitochondrial $O_{2}^{\bullet –}$ level comparable to that induced by TNF-α/CHX (**Figures [5A,C](#F5){ref-type="fig"}**), without affecting cell survival (**Figures [5B,D](#F5){ref-type="fig"}**). The concentration of 7.5 μM rotenone was selected based on a concentration-response study of the effect of rotenone on mitochondrial $O_{2}^{\bullet –}$, when incubated for 6 h to mimic the exposure time to TNF-α/CHX ([@B3]). Treatment with CORM-2 nearly abolished rotenone-induced mitochondrial $O_{2}^{\bullet –}$ production, whereas CORM-401 had no effect (**Figures [5A,C](#F5){ref-type="fig"}**).

![Effects of CORM-2 or CORM-401 on mitochondrial complex I (rotenone; Rot; **A--D**)- and mitochondrial complex III (antimycin-A; Ant-A; **E--H**)-induced mitochondrial $O_{2}^{\bullet –}$ production and cell death in MODE-K cells. MODE-K cells were treated for 6 h with rotenone (7.5 μM) or antimycin-A (10 μM) in the absence or presence of CORM-2 (40 μM; **A,B,E,F**) or CORM-401 (50 μM; **C,D,G,H**), added 1 h before rotenone or antimycin-A. Mitochondrial $O_{2}^{\bullet –}$ levels were assessed with MitoSOX Red, and gated on the viable, Sytox Red-negative population. Mitochondrial $O_{2}^{\bullet –}$ levels are expressed as % of control MitoSOX Red MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. rotenone or antimycin-A alone.](fphar-08-00031-g005){#F5}

The influence of CORM-2 and CORM-401 on mitochondrial $O_{2}^{\bullet –}$ production at the level of mitochondrial complex III was investigated by use of the complex III inhibitor antimycin-A, an agent well known to induce $O_{2}^{\bullet –}$ production at this site. Antimycin-A was used at 10 μM for 6 h ([@B3]) as this concentration did not induce cell death in MODE-K cells (see **Figures [5F,H](#F5){ref-type="fig"}**), but increased mitochondrial $O_{2}^{\bullet –}$ production to a level comparable to that induced by TNF-α/CHX (see **Figures [5E,G](#F5){ref-type="fig"}**). Both CORM-2 and CORM-401 significantly decreased (**Figures [5E,G](#F5){ref-type="fig"}**) antimycin-A-induced mitochondrial $O_{2}^{\bullet –}$ production.

iCORM-2 had no influence on the rotenone- or antimycin-A-induced increase in mitochondrial $O_{2}^{\bullet –}$ levels (data not shown).

Effects of CORM-2 and CORM-401 on TNF-α/CHX-Induced Changes in Mitochondrial Dysfunction and Mitochondrial Membrane Potential (Ψ~m~) of MODE-K Cells
----------------------------------------------------------------------------------------------------------------------------------------------------

Double staining of MODE-K cells with two different mitochondria-specific dyes to distinguish actively respiring (MitoTracker Deep Red FM-positive) and total (MitoTracker Green FM-positive) mitochondria revealed an increase in the number of respiration-interrupted mitochondria in the P2-gated region upon treatment of cells with TNF-α/CHX (representative examples in the third panel of **Figures [6A,C](#F6){ref-type="fig"}**) compared with untreated control cells (35--40% vs. 4--6%; **Figures [6B,D](#F6){ref-type="fig"}**). Treatment with CORM-2 (**Figures [6A,B](#F6){ref-type="fig"}**) significantly attenuated the TNF-α/CHX-induced increase in dysfunctional mitochondria, whereas treatment with CORM-401 did not have any effect on this parameter (**Figures [6C,D](#F6){ref-type="fig"}**).

![Effects of CORM-2 **(A,B)** or CORM-401 **(C,D)** on TNF-α/CHX-induced mitochondrial dysfunction in MODE-K cells. MODE-K cells were treated for 6 h with TNF-α (1 ng/ml)/CHX (10 μg/ml), in the absence and presence of CORM-2 (40 μM) or CORM-401 (50 μM), added 1 h before TNF-α/CHX. The number of cells with respiring mitochondria was assessed with MitoTracker Green FM (FL1; FITC) and MitoTracker Deep Red FM (FL4; APC). Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. **(A,C)** Representative dot plots of the flow cytometric analysis showing the effect of CORM-2 **(A)** or CORM-401 **(C)** on MitoTracker Green FM (total mitochondria) vs. MitoTracker Deep Red FM (actively respiring mitochondria) fluorescence of viable cells after treatment with TNF-α/CHX. Cells in the gated region (P2) contain respiration-interrupted mitochondria. **(B,D)** Quantification of flow cytometric measurements (expressed as % of cells with dysfunctional mitochondria) for experiments with CORM-2 **(B)** and CORM-401 **(D)**. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. TNF-α/CHX alone.](fphar-08-00031-g006){#F6}

We next studied the influence of CORM-2 and CORM-401 on TNF-α/CHX-induced changes in Ψ~m~ using a potentiometric dye, TMRM. TMRM facilitates analysis of cell death simultaneously in combination with the cell death marker Sytox Green. Approximately 7--8% of control cells showed depolarized mitochondria. Treatment of cells with TNF-α/CHX caused approximately 60% depolarization of mitochondria (**Figures [7A,C](#F7){ref-type="fig"}**). CORM-2 decreased the number of depolarized cells by TNF-α/CHX to 39% (**Figure [7A](#F7){ref-type="fig"}**) but CORM-401 did not influence this parameter (**Figure [7C](#F7){ref-type="fig"}**), whereas their inhibitory effect on TNF-α/CHX-induced cell death was confirmed (**Figures [7B,D](#F7){ref-type="fig"}**).

![Effects of CORM-2 **(A,B)** or CORM-401 **(C,D)** on TNF-α/CHX-induced changes in mitochondrial membrane potential and cell death in MODE-K cells. MODE-K cells were treated for 6 h with TNF-α (1 ng/ml)/CHX (10 μg/ml), incubated for 6 h, in the absence and presence of CORM-2 (40 μM) or CORM-401 (50 μM), added 1 h before TNF-α/CHX. Mitochondrial membrane potential was assessed with TMRM, and gated on the viable, Sytox Green-negative population. Mitochondrial membrane potential is expressed as % of cells with depolarized mitochondria as measured by TMRM staining; cell death is expressed as % Sytox Green positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 *per se* was also tested. Mean ± SEM of three independent experiments. ^∗^*P* \< 0.05 vs. control. ^\#^*P* \< 0.05 vs. TNF-α/CHX alone.](fphar-08-00031-g007){#F7}

iCORM-2 had no influence on the TNF-α/CHX-induced changes in both assays (data not shown).

Discussion
==========

TNF-α/CHX-induced apoptosis of MODE-K cells is associated with a marked production of ROS, the major sources being NOX and mitochondrial ETC complexes I and II ([@B6], [@B4]). One of the possible cellular mechanisms by which CO confers cytoprotection is via modulation of ROS production ([@B40]). We previously found that water-soluble CORM-A1 reduces TNF-α/CHX-induced apoptosis by inhibiting NOX-derived ROS production but not mitochondrial $O_{2}^{\bullet –}$ production induced by TNF-α ([@B6], [@B3]); treatment of MODE-K cells with CORM-A1 at concentrations that display a cytoprotective effect did not change basal mitochondrial $O_{2}^{\bullet –}$ production, even in the first hours after its administration. These results suggest that CORM-A1 is unable to interfere with sites of ROS production at the mitochondrial level; this result might be attributed to the water-soluble property of this CO-RM impairing its penetration into the cell and/or through the inner mitochondrial membrane ([@B26]). In the present study, we investigated the influence of the lipid-soluble CORM-2 under oxidative stress conditions in comparison with the newly developed water-soluble CORM-401, which was shown to release more equivalents of CO under oxidant conditions ([@B21]); see Table [2A](#T2a){ref-type="table"} for a qualitative summary of the effects of CORM-2 and CORM-401 in basal conditions and vs. TNF-α/CHX, rotenone, and antimycin-A treatment.

###### 

Qualitative summary of the effects of CORM-2 and CORM-401, incubated for 7 h, in basal conditions and vs. TNF-α/CHX, rotenone and antimycin-A treatment.

  --
  --

Mechanism of Action of CORM-2 during TNF-α/CHX-Induced Oxidative Stress
-----------------------------------------------------------------------

In contrast to previous results with CORM-A1 ([@B3]), pre- and co-incubation of MODE-K cells with CORM-2 abolished TNF-α/CHX-induced total cellular ROS production and markedly diminished cell death. CORM-2 also reduced TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production suggesting that CO released from CORM-2 can interfere at mitochondrial ROS production sites. CORM-2 indeed also reduced rotenone and antimycin-A-induced mitochondrial $O_{2}^{\bullet –}$ production demonstrating its capacity to mitigate complex I and complex III-derived ROS. The observed effects of CORM-2 can be attributed to the effect of CO released from it, as iCORM-2 both *per se* and in the presence of the stimuli (TNF-α/CHX, rotenone and antimycin-A) had no effect. Heme-containing proteins in mitochondria (cytochromes) and NOX enzymes in the cells are considered the major targets of CO due to the high affinity of CO for heme ([@B22]). At the mitochondrial level, CO is known to inhibit complex IV (cytochrome c oxidase), the terminal enzyme within the ETC, resulting in a significant transient burst of mitochondria-derived ROS ($O_{2}^{\bullet –}$). Several reports support that a partial inhibition of complex IV may create a preconditioning state to protect cells against subsequent oxidative insults ([@B14]; [@B58]; [@B30]). CORM-2 *per se* increased mitochondrial $O_{2}^{\bullet –}$ levels temporarily at 2 h of its incubation in MODE-K cells, whereas the total cellular ROS level measured at the same time point did not show any increase; the intracellular ROS detecting probe carboxy-H~2~DCFDA can indeed be oxidized by ROS types, such as H~2~O~2~ and hydroxyl radical but not $O_{2}^{\bullet –}$ ([@B37]). The early mitochondrial $O_{2}^{\bullet –}$ induction by CORM-2 might contribute to its cytoprotective effect against TNF-α/CHX treatment. The induction of mitochondrial $O_{2}^{\bullet –}$ production by CORM-2 *per se* and the reduction by CORM-2 of mitochondrial $O_{2}^{\bullet –}$ produced upon TNF-α/CHX, rotenone and antimycin-A treatment might be related to its lipid solubility. It seems plausible that the hydrophobic surface of CORM-2 enables its easy penetration through the outer and inner mitochondrial membrane, thus releasing CO inside the matrix. CORM-2 increased mitochondria-derived ROS as early as 30 min after its incubation with human airway smooth muscle cells ([@B49]). In MODE-K cells, measurable mitochondrial $O_{2}^{\bullet –}$ was observed only after 2 h incubation, but this does not exclude the induction of mitochondrial $O_{2}^{\bullet –}$ by CORM-2 before 2 h. We have previously identified that significant ROS production by TNF-α in MODE-K cells can only be observed from 2 h on, in contrast to other IECs, indicating that MODE-K cells are able to counteract the initial burst of oxidative stress up to this time point, after which the antioxidant defense can no longer be maintained ([@B4]). The results of the current study therefore suggest a role of the lipid-soluble nature of CORM-2 in interfering with mitochondrial ROS signaling in MODE-K IECs; further studies in other cell types are warranted to corroborate this phenomenon. Superoxide anion produced from NOX is converted into H~2~O~2~ by superoxide dismutase (SOD)-1 (Cu/ZnSOD) in the cytoplasm, whereas $O_{2}^{\bullet –}$ produced from mitochondria are either released as such into the cytoplasm by voltage-dependent anion channels (VDACs) or first converted into H~2~O~2~ by SOD-2 (MnSOD)/SOD-1 before diffusing across the mitochondrial membrane into the cytoplasm ([@B24]). CORM-2 only partially reduced TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production, so that some mitochondrial $O_{2}^{\bullet –}$ /H~2~O~2~ theoretically might leak into the cytoplasm in MODE-K cells. However, at least H~2~O~2~ should then contribute to the ROS signal picked up with carboxy-H~2~DCFDA and this part should not be influenced by treatment with CORM-2, as originating from mitochondrial $O_{2}^{\bullet –}$ not suppressed with CORM-2. As the increase in the DCF signal by TNF-α/CHX was fully abolished by CORM-2, this mitochondrial leakage does not seem to occur in MODE-K cells; this result further illustrates that CORM-2 abolishes NOX-derived ROS in MODE-K cells.

Mechanism of Action of CORM-401 during TNF-α/CHX-Induced Oxidative Stress
-------------------------------------------------------------------------

Similar to CORM-A1, CORM-401 reduced TNF-α/CHX-induced total cellular ROS production and cell death without any influence on TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production. Notably, CORM-401 *per se* did not have any effect on mitochondrial $O_{2}^{\bullet –}$ production. CORM-A1 attenuated the decrease in Ψ~m~ and the increase in mitochondrial dysfunction by TNF-α/CHX, which might be related to its inhibitory effect on mitochondrial respiration ([@B3]). By contrast, CORM-401 did not influence these mitochondrial effects mediated by TNF-α. The inability of CORM-401 to modulate TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$ production and other mitochondrial parameters seems to exclude mitochondria as a possible target influenced by CORM-401 during TNF-α/CHX-induced cell death. Complexes I and II of the ETC are the major mitochondrial ROS production sites during TNF-α/CHX-induced cell death in MODE-K cells ([@B4]). Consistent with the observation that CORM-401 does not influence TNF-α/CHX-induced mitochondrial $O_{2}^{\bullet –}$, CORM-401 was not able to reduce mitochondrial $O_{2}^{\bullet –}$ production by the complex I inhibitor rotenone. This result is probably related to the fact that rotenone-induced mitochondrial $O_{2}^{\bullet –}$ is released into the mitochondrial matrix ([@B13]; [@B43]). Indeed, as reported for CORM-A1 ([@B3]), CORM-401 was able to reduce antimycin-A-induced mitochondrial $O_{2}^{\bullet –}$ generation. This result could be attributed to the fact that the mitochondrial $O_{2}^{\bullet –}$ generated by the Qi site inhibitor of complex III antimycin-A is reported to be fully ([@B47]) or at least partially ([@B25]) released into the mitochondrial intermembrane space. Still, we have previously observed that myxothiazole, an inhibitor of complex III at the Qo site, partially reduced TNF-α/CHX-induced total ROS and cell death in MODE-K cells ([@B4]), implying that part of TNF-α/CHX-induced ROS must also be released into the mitochondrial intermembrane space. The lack of any effect of CORM-401 vs. TNF-α/CHX-induced mitochondrial ROS might be related to near full use of CORM-401-derived CO in the cytoplasm to counteract NOX-derived ROS upon exposure to TNF-α. As NOX enzymes are not activated by antimycin-A, a higher amount of CO from CORM-401 might reach the mitochondrial intermembrane space upon exposure of MODE-K cells to antimycin-A, resulting in a more pronounced reduction of mitochondrial $O_{2}^{\bullet –}$ than observed with CORM-2 treatment. As CORM-401 does not interfere with TNF-α/CHX-induced mitochondrial ROS, its inhibitory action on total cellular ROS induced by TNF-α/CHX treatment is exclusively related to inhibition of ROS derived from NOX, the second major source of TNF-α/CHX-induced ROS production. Inhibition of NOX by CO leading to decreased cytoplasmic $O_{2}^{\bullet –}$ production has been previously reported ([@B10]; [@B46]; [@B56]; [@B29]).

Differential Effects of CORM-2, CORM-A1 and CORM-401 during H~2~O~2~-Induced Cytotoxic Oxidative Stress
-------------------------------------------------------------------------------------------------------

The main cellular ROS involved in redox signaling is probably H~2~O~2~, as $O_{2}^{\bullet –}$ produced by various intracellular sources is either spontaneously or through SODs dismutated into H~2~O~2~. H~2~O~2~ is the most abundant ROS in cells; it is relatively stable and less toxic than other types of ROS and capable of diffusing across membranes ([@B9]). Physiologically, low endogenous levels of H~2~O~2~ function as signaling molecules for the regulation of eukaryotic signal transduction but endogenous overproduction of H~2~O~2~ is implicated in pathophysiological oxidative stress ([@B52]). Similarly, exogenous addition of higher concentrations of H~2~O~2~ leads to oxidative stress and apoptotic cell death ([@B53]). The degree of effect of CORM-2 and CORM-401 under oxidative stress conditions in comparison with CORM-A1 was therefore also investigated vs. H~2~O~2~-induced ROS in MODE-K cells (see Table [2B](#T2b){ref-type="table"} for a qualitative summary of the effects of CORM-2, CORM-401, and CORM-A1 vs. H~2~O~2~). Incubation of MODE-K cells with CORM-2 or CORM-401 from 1 h before and during exposure to a non-cytotoxic concentration of H~2~O~2~ (1 mM) for 40 min similarly reduced H~2~O~2~-induced intracellular total ROS levels, which is comparable to our earlier observation with CORM-A1 ([@B3]). However, when tested vs. 7.5 mM H~2~O~2~ for 1 h, inducing a similar level of cell death as TNF-α/CHX, but a much higher degree of total ROS, differences were observed for CORM-401 vs. CORM-2 and CORM-A1. CORM-401 is a water-soluble CO-RM with a half-life of CO release of 12-14 min; it is able to release up to three CO per mole of compound, whereas CORM-2 and CORM-A1 release one CO per mole of compound. Moreover, the release of CO is increased over time in the presence of biologically relevant oxidants, such as H~2~O~2~ ([@B21]). This acceleration of CO release from CORM-401 when more oxidants are present probably explains why CORM-401 is active in the presence of 7.5 mM H~2~O~2~ when co-incubating the cells with the compound only during the 1 h exposure to H~2~O~2~; the high degree of oxidative stress imposed by 7.5 mM H~2~O~2~ can be expected to maximally accelerate CO release from CORM-401. This effect does not occur with CORM-2 and CORM-A1, which were ineffective with this treatment protocol. Surprisingly, CORM-401 was also mildly effective when only pre-incubated for 1 h before exposure of the cells to 7.5 mM H~2~O~2~. There is not a high ROS level in MODE-K cells before exposure to 7.5 mM H~2~O~2~; thus, CO release from CORM-401 is not accelerated. Still, the amount of CO released from CORM-401 seems sufficient to provide some protection to the cells against 7.5 mM H~2~O~2~ after washout of CORM-401. We do not have a definitive explanation for this observation, which did not occur with CORM-2 and CORM-A1. Both these compounds were only effective vs. 7.5 mM H~2~O~2~ upon 1 h pre-incubation plus 1 h co-incubation. As no real iCORM-401 can be prepared, some influence of the scaffold of CORM-401 cannot fully be excluded.

###### 

Qualitative summary of the effects of CORM-2, CORM-401 and CORM-A1 vs. H~2~O~2~ treatment (1 mM for 40 min and 7.5 mM for 1 h).

  --
  --

Conclusion
==========

CORM-2 and CORM-401 show differential cytoprotective effects under oxidative stress conditions in MODE-K IECs. Both CORM-2 and CORM-401 show antioxidant and cytoprotective effects under oxidative stress associated with inflammation (TNF-α/CHX). The cytoprotective effect of CORM-401 mitigates NOX-derived ROS, whereas CORM-2 interferes with both NOX and mitochondria-derived ROS to protect MODE-K cells from TNF-α/CHX-induced cell death; the mitochondrial effect of CORM-2 might be related to its lipophilicity. CORM-401 was more effective than CORM-2 in protecting cells against oxidative stress and cell death, induced by a high concentration of exogenous H~2~O~2~. This result might be related to the ability of CORM-401 to release more CO under oxidative conditions, suggesting that this compound may be effective under conditions of persistent oxidative stress such as in the case of acute and chronic GI disorders. Once probes are available allowing to analyze the subcellular location of released CO, it will be possible to investigate whether CO released from different CO-RMs can show a different subcellular trajectory.
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